Similar articles

• The clinical use of human leukocyte interferon in viral infections.

  Ikić D, Trajer D, Cupak K, Petricević I, Prazić M, Soldo I, Jusic D, Smerdel S, Soos E. Ikić D, et al. Int J Clin Pharmacol Ther Toxicol. 1981 Nov;19(11):498-505. Int J Clin Pharmacol Ther Toxicol. 1981. PMID: 6170597 Review.
• [Treatment of dermatoses of viral and non-viral etiology with interferon].

  Borzov MV, Kuznetsov VP, Lobanovskiĭ GI. Borzov MV, et al. Vrach Delo. 1974;4:149-51. Vrach Delo. 1974. PMID: 4831848 Russian. No abstract available.
• Prospects for the clinical use of exogenous interferon.

  Cantell K. Cantell K. Med Biol. 1977 Apr;55(2):69-73. Med Biol. 1977. PMID: 194114 Review.
• [Use of interferons and interferonogens in dermatology (a review)].

  Shcherbakov IM. Shcherbakov IM. Vestn Dermatol Venerol. 1973 Mar;47(3):8-13. Vestn Dermatol Venerol. 1973. PMID: 4581062 Review. Russian. No abstract available.
• [Experimental-clinical study of endogenous and exogenous interferons].

  Ermol'eva ZV, Furer NM, Pokidova NV, Nemirovskaia BM, Kuznetsov VP, Rapoport RI, Blinova MI, Popov NV. Ermol'eva ZV, et al. Antibiotiki. 1967 Nov;12(11):1034-9. Antibiotiki. 1967. PMID: 4298567 Russian. No abstract available.